American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Master protocol to assess the safety and recommended Phase 2 dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma and non-small cell lung cancer
    Meeting Abstract

    Schoenfeld, A. J.; Altan, M.; Owonikoko, T. K.; D'Angelo, S.; Ladle, B. H.; Noujaim, J.; He, K.; Liebner, D.; Sacher, A. G.; Haanen, J. B. A. G.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • HSF1 promotes inflammation induced tumor development through ECM remodeling
    Meeting Abstract

    Galibov, O. L.; Lavon, H.; Wassermann-Dozorets, R.; Pevsner-Fischer, M.; Mayer, S.; Wershof, E.; Stein, Y.; Brown, L. E.; Zhang, W.; Friedman, G.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Addition of parsaclisib (INCB050465), a PI3Kδ inhibitor, in patients with suboptimal response to ruxolitinib: A phase 2 study in patients with myelofibrosis
    Meeting Abstract

    Yacoub, A.; Wang, E. S.; Rampal, R. K.; Borate, U.; Kremyanskaya, M.; Ali, H.; Hobbs, G. S.; O'Connell, C.; Assad, A.; Erickson-Viitanen, S.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Phase I immunovirotherapy trial of oncolytic HSV-1 G207 alone or combined with radiation in pediatric high-grade glioma
    Meeting Abstract

    Friedman, G. K.; Johnston, J. M.; Bag, A. K.; Bernstock, J. D.; Li, R.; Aban, I.; Kachurak, K.; Nan, L.; Kang, K. D.; Totsch, S.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Transcriptome-wide association study of endometrial cancer risk
    Meeting Abstract

    Zhu, J.; O'Mara, T. A.; Setiawan, V. W.; Du, M. M.; ECAC consortium; Friedenreich, C.; Cook, L. S.; Lacey, J.; Chen, C.; Johnson, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Phase 1 first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumors
    Meeting Abstract

    Powderly, J.; Shimizu, T.; LoRusso, P.; Razak, A.; Miller, K.; Balar, A.; Bruix, J.; Michel, L.; Blaney, M.; Guan, X.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Population pharmacokinetics of ripretinib in patients with advanced malignancies
    Meeting Abstract

    George, S.; Janku, F.; Chi, P.; von Mehren, M.; Somaiah, N.; Gelderblom, H.; Jones, R. L.; Allard, M.; Taylor, A.; Li, X.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Multidimensional metabolomic stratification of ER+/HER2- compared to ER-/HER2- breast tumors
    Meeting Abstract

    Bussberg, V.; Tolstikov, V.; Wang, G.; Shah, P.; Searfoss, R.; Fantacone-Campbell, L.; Hooke, J. A.; Deyarmin, B.; Zingmark, R. N.; Somiari, S.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • HMGA1: An epigenetic switch required for MPN progression by inducing GATA-2 and cell cycle progression through enhancer rewiring
    Meeting Abstract

    Li, L.; Kim, J. H.; Lu, W.; Williams, D. M.; Xian, L.; Kim, J.; Rogers, O.; Rampal, R. K.; Koche, R. P.; Cope, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Monitoring circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) genomic alterations in ER positive (POS)/HER2 negative (NEG) advanced breast cancer during endocrine therapy: Correlative study of AZD9496 oral SERD phase I trial
    Meeting Abstract

    Cani, A. K.; Dolce, E. M.; Darga, E. P.; Hu, K.; Brown, M.; Liu, C. J.; Pierce, J.; Bradbury, K.; Aung, K.; Schiavon, G.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: